Marjorie Westervelt, PhD, MPH, Darius Billingsley, MD, Maya London, and Tonya Fancher, MD, MPH
Retention, student progression, and career advancement milestones are at least as important as admissions in promoting just medical education opportunity.
AMA J Ethics. 2021;23(12):E937-945. doi:
10.1001/amajethics.2021.937.
Barbara Barzansky, PhD, MHPE, Robert B. Hash, MD, MBA, Veronica Catanese, MD, MBA, and Donna Waechter, PhD
Diversity standards in medical education accreditation do not guarantee diversity but stimulate schools’ activities to recruit and retain diverse students and faculty.
AMA J Ethics. 2021;23(12):E946-952. doi:
10.1001/amajethics.2021.946.
The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention.
AMA J Ethics. 2021;23(1):E49-54. doi:
10.1001/amajethics.2021.49.
Dr Adela Valdez joins Ethics Talk to discuss her article, coauthored with Lala Forrest, Alessandra Jimenez, and Dr Kim-Thu Pham: “How Should Medical Schools Foster Equity and Inclusion in Admissions?”
Dr Tonya Fancher joins Ethics Talk to discuss her article, coauthored with Dr Marjorie Westervelt, Dr Darius Billingsley, and Maya London: “Three Things Schools Should Do to Make Advancement Assessment Just”
Dr Barbara Barzansky joins Ethics Talk to discuss her article, coauthored with Drs Robert B. Hash, Veronica Catanese, and Donna Waechter: “What Is the Role of Accreditation in Achieving Medical School Diversity?”
Bjorg Thorsteinsdottir, MD, Annika Beck, and Jon C. Tilburt, MD, MPH
Good clinicians understand why a patient is asking for a test or treatment, and their skillful counseling can often stem the tide of requests for marginally beneficial tests and procedures.
AMA J Ethics. 2015;17(11):1028-1034. doi:
10.1001/journalofethics.2015.17.11.ecas2-1511.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"